Browsing by Subject "COVID-19"
Now showing items 1-20 of 78
-
A comparison of COVID-19 and imaging radiation risk in clinical patient populations.
(J Radiol Prot, 2020-10-07)OBJECTIVE: The outbreak of coronavirus SARS-COV2 affected more than 180 countries necessitating fast and accurate diagnostic tools. Reverse transcriptase polymerase chain reaction (RT-PCR) has been identified as a gold standard ... -
A National Decision Point: Effective Testing and Screening for Covid-19
(2020-09-09)This Duke-Margolis report out provides a framework for public health officials and community leaders in schools, businesses and other institutions on how to use Covid-19 screening test strategies to operate safely and prevent ... -
Activity of Galidesivir in a Hamster Model of SARS-CoV-2.
(Viruses, 2021-12-21)Coronavirus disease 2019 (COVID-19) has claimed the lives of millions of people worldwide since it first emerged. The impact of the COVID-19 pandemic on public health and the global economy has highlighted the medical need ... -
Addressing the "Elephant in the Room": Rumor Rebuttal in China during the COVID-19 Outbreak
(2021)This study aims to explain the logic behind rumor rebuttal, a form of responsivepropaganda, in authoritarian countries during COVID-19, the story of which initially unfolded as ”rumor”. Taking China at the beginning stage ... -
Addressing the Impact of COVID-19 on Immigrant and Refugee Children and Families at a Federally Qualified Health Center in Durham, North Carolina.
(2021)Background: The COVID-19 pandemic amplified disparities experienced by children in immigrant and refugee families (CIRF). The pandemic coincided with a recognition that proactively screening and addressing social risk drivers ... -
Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents, and young adults.
(Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022-03-05)<h4>Background</h4>Children are less susceptible to SARS-CoV-2 infection and typically have milder illness courses than adults, but the factors underlying these age-associated differences are not well understood. The upper ... -
Betting on Better Drug Trials to Beat Covid-19
(Wall Street journal (Eastern ed.), 2020-08-23) -
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
(Stem cells translational medicine, 2020-09)Severe cases of COVID-19 infection, often leading to death, have been associated with variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal stromal cells (MSCs) is a potential treatment for ... -
Characterizing and combatting thromboinflammation in infection and autoimmune disease
(2021)Coagulation and inflammation are intimately linked processes that protect the body from a wide range of insults. However, dysregulation of this system contributes to morbidity and mortality in infection, autoimmune disease, ... -
Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19.
(Nucleic acid therapeutics, 2022-01-12)Known limitations of unfractionated heparin (UFH) have encouraged the evaluation of anticoagulant aptamers as alternatives to UFH in highly procoagulant settings such as cardiopulmonary bypass (CPB). Despite progress, these ... -
Compiling Observational Research During a Pandemic: A Necessary Bridge.
(Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020-12-11) -
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial.
(American heart journal, 2020-08)Angiotensin-converting enzyme-2 (ACE2) expression may increase due to upregulation in patients using angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs). Because renin-angiotensin system ... -
Coronavirus disease 2019 (COVID-19): an evidence map of medical literature.
(BMC medical research methodology, 2020-07-02)<h4>Background</h4>Since the beginning of the COVID-19 outbreak in December 2019, a substantial body of COVID-19 medical literature has been generated. As of June 2020, gaps and longitudinal trends in the COVID-19 medical ... -
Covid Shows the Need for a Diagnostic Stockpile
(Wall Street journal (Eastern ed.), 2020-07-26) -
COVID-19 and Housing Security: Assessing Equity & Efficiency Across North Carolina’s Emergency Rental Assistance Programs
(2021-04-19)COVID-19 has exacerbated the nation’s existing affordable crisis, putting approximately 14 million Americans out of work, and leading to widespread housing insecurity nationwide. This hardship has disproportionately affected ... -
COVID-19 Manufacturing for Monoclonal Antibodies
(2020-08-01) -
COVID-19-associated brief psychotic disorder.
(BMJ case reports, 2020-08-11)A 36-year-old previously healthy woman with no personal or family history of mental illness presented with new-onset psychosis after a diagnosis of symptomatic COVID-19. Her psychotic symptoms initially improved ... -
COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications.
(SN comprehensive clinical medicine, 2020-11-21)The concurrence of COVID-19 with Guillain-Barre syndrome (GBS) can increase the likelihood of neuromuscular respiratory failure, autonomic dysfunction, and other life-threatening symptoms. Currently, very little is known ... -
COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection.
(International journal of environmental research and public health, 2021-08-11)<h4>Background</h4>We performed an observational Veterans Health Administration cohort analysis to assess how risk factors affect 30-day mortality in SARS-CoV-2-infected subjects relative to those uninfected. While the risk ...